Company / Inventory
Insulet Corporation Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$452.6M
FY2025
5-year range
$303.2M / $452.6M
FY2021-FY2025
Trend
+5.2%
vs FY2024
Sector context
#45 of 118
Health Care
What the data says
At $453M, Insulet Corporation's inventory ranks #45 of 118 in the Health Care sector. Inventory has increased for 8 consecutive years, from $34M in FY2017 to $453M in FY2025.
Based on SEC 10-K filings.
$453M in FY2025 with a 5-year CAGR of +24.0%.
Improved from $403M to $453M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +9.3%
- 5-Year CAGR
- +24.0%
- 10-Year CAGR
- -
Sector benchmark
#45 of 118 in Health CareTop 38% of 118This company $452.6M Sector average $1.4B
▼
-68.2% below sector average
Key checks
Key Insights
- Insulet Corporation's inventory has grown for 8 consecutive years.
- 5-year CAGR of +24.0%, indicating consistent growth.
- In FY2025, inventory increased 5.2% year-over-year.
- Ranks #45 out of 118 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $452.6M | +5.2% |
| FY2024 | $430.4M | +6.9% |
| FY2023 | $402.6M | +16.1% |
| FY2022 | $346.8M | +14.4% |
| FY2021 | $303.2M | +96.5% |
| FY2020 | $154.3M | +52.8% |
| FY2019 | $101.0M | +41.5% |
| FY2018 | $71.4M | +111.3% |
| FY2017 | $33.8M | -4.8% |
| FY2016 | $35.5M | +195.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026